Silence Therapeuticsの空売り状況は、投資家がSilence Therapeuticsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Silence Therapeutics (NASDAQ:SLN) 株価情報, 空売り情報

SILENCE THERAPEUTICS PLC-ADR

Silence Therapeutics

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics PLC

SELINA HOSPITALITY PLC HS

SELINA HOSPITALITY PLC by Selina Hospitality PLC

Selina Hospitality PLC

SILENCE THERAPEUTICS ORD by Silence Therapeutics, Plc.

Southland Holdings Inc

SOLUTION FINL INC by Solution Financial Inc.

Solution Financial Inc

Stabilis Solutions Inc

Soluna Holdings Inc

Soluna Holdings, Inc. - 9.0% Series A Cumulative Perpetual Preferred Stock

STELLA INTL HLDGS LTD ORD by Stella International Holdings Ltd.

Stella International Holdings Ltd

STELLA INTL HLDG UNSP/ADR by Stella International Holdings Ltd.

SALON MEDIA GROUP INC by Salon Media Group, Inc.

Salon Media Group Inc

Soleno Therapeutics Inc

SOLUTIONS 30 SE UNSP/ADR by Solutions 30 S.E.

Solutions 30 SE

Selina Hospitality PLC Warrants (27/10/2027)

SOLANBRIDGE GROUP INC by Solanbridge Group, Inc.

Solanbridge Group Inc

TCW Senior Loan ETF

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/25/25</td>
<td>$90.00</td>
<td>$50.5K</td>
<td>174</td>
<td>62.4K</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$380.00</td>
<td>$91.5K</td>
<td>3.6K</td>
<td>6.4K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$25.00</td>
<td>$52.7K</td>
<td>21.5K</td>
<td>1.2K</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$90.00</td>
<td>$32.6K</td>
<td>2.7K</td>
<td>880</td>
</tr>
<tr>
<td>XYZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$70.00</td>
<td>$99.7K</td>
<td>3.2K</td>
<td>349</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$685.00</td>
<td>$44.8K</td>
<td>153</td>
<td>174</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$90.00</td>
<td>$26.6K</td>
<td>152</td>
<td>131</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$145.00</td>
<td>$47.7K</td>
<td>317</td>
<td>69</td>
</tr>
<tr>
<td>V</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$325.00</td>
<td>$231.8K</td>
<td>45</td>
<td>51</td>
</tr>
<tr>
<td>LMND</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$42.00</td>
<td>$35.2K</td>
<td>35</td>
<td>42</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding C (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), we observe a call option sweep with bullish sentiment. It expires in 29 day(s) on July 25, 2025. Parties traded 500 contract(s) at a $90.00 strike. This particular call needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $50.5K, with a price of $101.0 per contract. There were 174 open contracts at this strike prior to today, and today 62481 contract(s) were bought and sold. 
• Regarding COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we observe a call option trade with bullish sentiment. It expires in 7 day(s) on July 3, 2025. Parties traded 80 contract(s) at a $380.00 strike. The total cost received by the writing party (or parties) was $91.5K, with a price of $1144.0 per contract. There were 3601 open contracts at this strike prior to today, and today 6447 contract(s) were bought and sold. 
• For SOFI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>), we notice a call option sweep that happens to be bullish, expiring in 568 day(s) on January 15, 2027. This event was a transfer of 197 contract(s) at a $25.00 strike. This particular call needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $52.7K, with a price of $268.0 per contract. There were 21522 open contracts at this strike prior to today, and today 1245 contract(s) were bought and sold. 
• Regarding HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we observe a call option sweep with bullish sentiment. It expires in 113 day(s) on October 17, 2025. Parties traded 31 contract(s) at a $90.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $32.6K, with a price of $1053.0 per contract. There were 2728 open contracts at this strike prior to today, and today 880 contract(s) were bought and sold. 
• For XYZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>), we notice a call option sweep that happens to be bearish, expiring in 204 day(s) on January 16, 2026. This event was a transfer of 134 contract(s) at a $70.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $99.7K, with a price of $744.0 per contract. There were 3286 open contracts at this strike prior to today, and today 349 contract(s) were bought and sold. 
• For GS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), we notice a call option sweep that happens to be bullish, expiring in 22 day(s) on July 18, 2025. This event was a transfer of 20 contract(s) at a $685.00 strike. This particular call needed to be split into 12 different trades to become filled. The total cost received by the writing party (or parties) was $44.8K, with a price of $2240.0 per contract. There were 153 open contracts at this strike prior to today, and today 174 contract(s) were bought and sold. 
• For AFRM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), we notice a call option trade that happens to be bullish, expiring in 357 day(s) on June 18, 2026. This event was a transfer of 25 contract(s) at a $90.00 strike. The total cost received by the writing party (or parties) was $26.6K, with a price of $1065.0 per contract. There were 152 open contracts at this strike prior to today, and today 131 contract(s) were bought and sold. 
• For MS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), we notice a call option trade that happens to be bearish, expiring in 357 day(s) on June 18, 2026. This event was a transfer of 35 contract(s) at a $145.00 strike. The total cost received by the writing party (or parties) was $47.7K, with a price of $1365.0 per contract. There were 317 open contracts at this strike prior to today, and today 69 contract(s) were bought and sold. 
• For V (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), we notice a call option sweep that happens to be bearish, expiring in 540 day(s) on December 18, 2026. This event was a transfer of 39 contract(s) at a $325.00 strike. This particular call needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $231.8K, with a price of $5945.0 per contract. There were 45 open contracts at this strike prior to today, and today 51 contract(s) were bought and sold. 
• Regarding LMND (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>), we observe a call option trade with bullish sentiment. It expires in 267 day(s) on March 20, 2026. Parties traded 30 contract(s) at a $42.00 strike. The total cost received by the writing party (or parties) was $35.2K, with a price of $1175.0 per contract. There were 35 open contracts at this strike prior to today, and today 42 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AFRM

COIN

HOOD

LMND

SOFI

10 Financials Stocks Whale Activity In Today's Session

<a href="https://www.youtube.com/watch?v=NKl2dpLylK0">https://www.youtube.com/watch?v=NKl2dpLylK0</a>

News

General

White House Says No Imminent Plans For Refilling Strategic Petroleum Reserve

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/27/25</td>
<td>$330.00</td>
<td>$35.3K</td>
<td>18.2K</td>
<td>93.8K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/27/25</td>
<td>$215.00</td>
<td>$43.8K</td>
<td>31.2K</td>
<td>50.2K</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$55.00</td>
<td>$96.6K</td>
<td>12.1K</td>
<td>2.9K</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/03/25</td>
<td>$61.00</td>
<td>$31.5K</td>
<td>3.0K</td>
<td>2.1K</td>
</tr>
<tr>
<td>HSAI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$20.00</td>
<td>$29.9K</td>
<td>1.2K</td>
<td>965</td>
</tr>
<tr>
<td>EAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$130.00</td>
<td>$90.1K</td>
<td>3.5K</td>
<td>707</td>
</tr>
<tr>
<td>LI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$27.00</td>
<td>$182.5K</td>
<td>465</td>
<td>607</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$200.00</td>
<td>$50.7K</td>
<td>212</td>
<td>81</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$140.00</td>
<td>$37.7K</td>
<td>9</td>
<td>55</td>
</tr>
<tr>
<td>MELI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$2800.00</td>
<td>$940.5K</td>
<td>128</td>
<td>45</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we observe a call option sweep with bearish sentiment. It expires in 1 day(s) on June 27, 2025. Parties traded 101 contract(s) at a $330.00 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $35.3K, with a price of $350.0 per contract. There were 18260 open contracts at this strike prior to today, and today 93841 contract(s) were bought and sold. 
• Regarding AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we observe a call option trade with bearish sentiment. It expires in 1 day(s) on June 27, 2025. Parties traded 200 contract(s) at a $215.00 strike. The total cost received by the writing party (or parties) was $43.8K, with a price of $219.0 per contract. There were 31250 open contracts at this strike prior to today, and today 50224 contract(s) were bought and sold. 
• Regarding CMG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), we observe a call option sweep with bullish sentiment. It expires in 7 day(s) on July 3, 2025. Parties traded 2597 contract(s) at a $55.00 strike. This particular call needed to be split into 21 different trades to become filled. The total cost received by the writing party (or parties) was $96.6K, with a price of $37.0 per contract. There were 12103 open contracts at this strike prior to today, and today 2949 contract(s) were bought and sold. 
• Regarding NKE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), we observe a put option sweep with bearish sentiment. It expires in 7 day(s) on July 3, 2025. Parties traded 151 contract(s) at a $61.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $31.5K, with a price of $209.0 per contract. There were 3057 open contracts at this strike prior to today, and today 2187 contract(s) were bought and sold. 
• Regarding HSAI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>), we observe a call option sweep with neutral sentiment. It expires in 22 day(s) on July 18, 2025. Parties traded 100 contract(s) at a $20.00 strike. This particular call needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $29.9K, with a price of $299.0 per contract. There were 1224 open contracts at this strike prior to today, and today 965 contract(s) were bought and sold. 
• Regarding EAT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>), we observe a call option sweep with bearish sentiment. It expires in 204 day(s) on January 16, 2026. Parties traded 15 contract(s) at a $130.00 strike. This particular call needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $90.1K, with a price of $6010.0 per contract. There were 3558 open contracts at this strike prior to today, and today 707 contract(s) were bought and sold. 
• Regarding LI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>), we observe a put option sweep with bullish sentiment. It expires in 267 day(s) on March 20, 2026. Parties traded 500 contract(s) at a $27.00 strike. This particular put needed to be split into 23 different trades to become filled. The total cost received by the writing party (or parties) was $182.5K, with a price of $365.0 per contract. There were 465 open contracts at this strike prior to today, and today 607 contract(s) were bought and sold. 
• For LULU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>), we notice a call option trade that happens to be neutral, expiring in 204 day(s) on January 16, 2026. This event was a transfer of 10 contract(s) at a $200.00 strike. The total cost received by the writing party (or parties) was $50.7K, with a price of $5075.0 per contract. There were 212 open contracts at this strike prior to today, and today 81 contract(s) were bought and sold. 
• For BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we notice a call option sweep that happens to be neutral, expiring in 568 day(s) on January 15, 2027. This event was a transfer of 25 contract(s) at a $140.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $37.7K, with a price of $1500.0 per contract. There were 9 open contracts at this strike prior to today, and today 55 contract(s) were bought and sold. 
• For MELI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>), we notice a call option trade that happens to be bullish, expiring in 204 day(s) on January 16, 2026. This event was a transfer of 45 contract(s) at a $2800.00 strike. The total cost received by the writing party (or parties) was $940.5K, with a price of $20900.0 per contract. There were 128 open contracts at this strike prior to today, and today 45 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMZN

BABA

HSAI

LULU

MELI

TSLA

10 Consumer Discretionary Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Information Technology sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/27/25</td>
<td>$155.00</td>
<td>$104.4K</td>
<td>109.7K</td>
<td>244.6K</td>
</tr>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$15.00</td>
<td>$76.6K</td>
<td>22.1K</td>
<td>16.3K</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$13.00</td>
<td>$157.9K</td>
<td>18.6K</td>
<td>9.5K</td>
</tr>
<tr>
<td>MRVL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/27/25</td>
<td>$75.00</td>
<td>$28.2K</td>
<td>14.1K</td>
<td>8.3K</td>
</tr>
<tr>
<td>INTC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$23.00</td>
<td>$106.5K</td>
<td>17.5K</td>
<td>5.7K</td>
</tr>
<tr>
<td>AMD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$155.00</td>
<td>$83.3K</td>
<td>16.1K</td>
<td>3.1K</td>
</tr>
<tr>
<td>CRCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/27/25</td>
<td>$200.00</td>
<td>$63.6K</td>
<td>2.6K</td>
<td>2.1K</td>
</tr>
<tr>
<td>QUBT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$17.00</td>
<td>$41.3K</td>
<td>661</td>
<td>975</td>
</tr>
<tr>
<td>AVGO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/27/25</td>
<td>$270.00</td>
<td>$30.6K</td>
<td>566</td>
<td>974</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$230.00</td>
<td>$101.8K</td>
<td>8.2K</td>
<td>706</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a call option sweep that happens to be bullish, expiring in 1 day(s) on June 27, 2025. This event was a transfer of 567 contract(s) at a $155.00 strike. This particular call needed to be split into 18 different trades to become filled. The total cost received by the writing party (or parties) was $104.4K, with a price of $185.0 per contract. There were 109745 open contracts at this strike prior to today, and today 244656 contract(s) were bought and sold. 
• For CORZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>), we notice a call option trade that happens to be bullish, expiring in 50 day(s) on August 15, 2025. This event was a transfer of 428 contract(s) at a $15.00 strike. The total cost received by the writing party (or parties) was $76.6K, with a price of $179.0 per contract. There were 22190 open contracts at this strike prior to today, and today 16304 contract(s) were bought and sold. 
• For IREN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>), we notice a call option sweep that happens to be bearish, expiring in 22 day(s) on July 18, 2025. This event was a transfer of 1500 contract(s) at a $13.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $157.9K, with a price of $106.0 per contract. There were 18664 open contracts at this strike prior to today, and today 9557 contract(s) were bought and sold. 
• Regarding MRVL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>), we observe a call option sweep with bullish sentiment. It expires in 1 day(s) on June 27, 2025. Parties traded 57 contract(s) at a $75.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $28.2K, with a price of $495.0 per contract. There were 14123 open contracts at this strike prior to today, and today 8316 contract(s) were bought and sold. 
• Regarding INTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), we observe a call option sweep with bullish sentiment. It expires in 7 day(s) on July 3, 2025. Parties traded 3791 contract(s) at a $23.00 strike. This particular call needed to be split into 30 different trades to become filled. The total cost received by the writing party (or parties) was $106.5K, with a price of $28.0 per contract. There were 17553 open contracts at this strike prior to today, and today 5709 contract(s) were bought and sold. 
• Regarding AMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), we observe a call option sweep with bearish sentiment. It expires in 22 day(s) on July 18, 2025. Parties traded 391 contract(s) at a $155.00 strike. This particular call needed to be split into 35 different trades to become filled. The total cost received by the writing party (or parties) was $83.3K, with a price of $213.0 per contract. There were 16194 open contracts at this strike prior to today, and today 3159 contract(s) were bought and sold. 
• For CRCL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>), we notice a call option trade that happens to be bearish, expiring in 1 day(s) on June 27, 2025. This event was a transfer of 30 contract(s) at a $200.00 strike. The total cost received by the writing party (or parties) was $63.6K, with a price of $2120.0 per contract. There were 2691 open contracts at this strike prior to today, and today 2148 contract(s) were bought and sold. 
• Regarding QUBT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>), we observe a put option sweep with bullish sentiment. It expires in 7 day(s) on July 3, 2025. Parties traded 516 contract(s) at a $17.00 strike. This particular put needed to be split into 15 different trades to become filled. The total cost received by the writing party (or parties) was $41.3K, with a price of $80.0 per contract. There were 661 open contracts at this strike prior to today, and today 975 contract(s) were bought and sold. 
• For AVGO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), we notice a put option sweep that happens to be bullish, expiring in 1 day(s) on June 27, 2025. This event was a transfer of 120 contract(s) at a $270.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $30.6K, with a price of $255.0 per contract. There were 566 open contracts at this strike prior to today, and today 974 contract(s) were bought and sold. 
• Regarding AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we observe a call option trade with bearish sentiment. It expires in 568 day(s) on January 15, 2027. Parties traded 51 contract(s) at a $230.00 strike. The total cost received by the writing party (or parties) was $101.8K, with a price of $1998.0 per contract. There were 8290 open contracts at this strike prior to today, and today 706 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

AVGO

Core Scientific, Inc. - Class A Common Stock

CORZ

CRCL

INTC

IREN

MRVL

NVDA

QUBT

10 Information Technology Stocks Whale Activity In Today's Session

BMO Capital analyst Brian Quast downgrades Ascot Resources (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AOT#TSX">AOT</a>) from Outperform to Market Perform.

Downgrades

Analyst Ratings

TSX:AOT

BMO Capital Downgrades Ascot Resources to Market Perform

<a href="https://techcrunch.com/2025/06/26/rivian-cuts-dozens-on-manufacturing-team-ahead-of-r2-launch/">https://techcrunch.com/2025/06/26/rivian-cuts-dozens-on-manufacturing-team-ahead-of-r2-launch/</a>

RIVN

'Rivian cuts dozens on manufacturing team ahead of R2 launch'- Techcrunch

Susquehanna analyst Mehdi Hosseini maintains Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) with a Positive and raises the price target from $150 to $160.

Price Target

Susquehanna Maintains Positive on Micron Technology, Raises Price Target to $160

Starbucks Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) is reportedly navigating heightened union tensions as Workers United launches a bold initiative encouraging labor organizers<a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/46053495/starbucks-green-apron-expansion-to-boost-service-but-squeeze-earnings-through-2027" rel="noreferrer noopener"> to apply for barista roles</a>.
The union&#8217;s move coincides with Starbucks&#8217; plans to bolster store staffing, potentially turning the company&#8217;s hiring spree into an unexpected organizing opportunity, Financial Times <a target="_blank" href="https://www.ft.com/content/89218b42-630e-4e8e-9720-b6b680c2022e" rel="noreferrer noopener">reports</a>.
Through a public campaign on social media, Workers United is recruiting &#8220;salts&#8221;—activists who seek employment with the aim of organizing from within.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/06/46066854/starbucks-denies-full-china-exit-amid-stake-sale-talks-as-market-share-slips-to-14" rel="noreferrer noopener">Starbucks Denies Full China Exit Amid Stake Sale Talks As Market Share Slips To 14%</a>
The initiative comes as the union has successfully won elections at 600 of Starbucks&#8217; more than 10,300 U.S. company-operated locations,
Starbucks executives recently acknowledged that prior staffing cuts weakened customer service. They subsequently announced a plan to expand headcount starting in August.
Last month, the union posted a call for applicants to join a new program that would assist them in landing jobs and organizing efforts from inside the cafés.
This open recruitment for salting reflects a strategic escalation and comes amid ongoing—but tense—contract negotiations with Starbucks. Walkouts over a new dress code last month underscored the strained relationship.
Starbucks criticized the union&#8217;s recruitment campaign, urging it to redirect energy toward finalizing a contract.
Sara Kelly, Starbucsk Chief Partner Officer, noted that more than 30 tentative agreements had been reached. She also warned against using resources to insert outside organizers, Financial Times adds.
Cornell labor expert Kate Bronfenbrenner explained that publicizing salting efforts signals sustained union pressure and intent to continue organizing efforts regardless of company resistance.
Meanwhile, Starbucks is denying reports it is considering a full exit from China. A spokesperson told Reuters the company isn't pursuing a full sale.
The Seattle-based company reportedly initiated a formal sale process in May, <a href="https://www.benzinga.com/markets/equities/25/06/46066854/starbucks-denies-full-china-exit-amid-stake-sale-talks-as-market-share-slips-to-14">with Goldman Sachs advising</a>.
Price Action: SBUX shares are trading lower by 0.48% to $90.62 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46117348/meta-secures-more-clean-energy-for-power-hungry-ai-and-data-center-growth" target="_blank" rel="noreferrer noopener">Meta Secures More Clean Energy For Power Hungry AI And Data Center Growth</a></li>
</ul>
Image: Shutterstock

Equities

Markets

Movers

SBUX

Union 'Salts' Stir The Pot As Starbucks Ramps Up Hiring

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) is approaching a pivotal support zone that could define its trend for <a href="https://www.benzinga.com/money/dogecoin-doge-price-prediction">the remainder of the cycle</a>.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Ticker</td>
<td>Price</td>
<td>Market Cap</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Dogecoin</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1598</td>
<td>&nbsp;$23.9 billion</td>
<td>-5.6%&nbsp;</td>
</tr>
<tr>
<td>Shiba Inu</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001122</td>
<td>&nbsp;$6.6 billion</td>
<td>-2.4%&nbsp;</td>
</tr>
<tr>
<td>Pepe</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>$0.059214</td>
<td>&nbsp;$3.9 billion</td>
<td>-10.3%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto analyst Kevin has <a href="https://x.com/Kev_Capital_TA/status/1938218851134489002">flagged</a> the $0.143–$0.127 range as the make-or-break level for Dogecoin. 
This zone aligns with a cluster of technical supports: the 200-week SMA/EMA, a long-term downtrend support line, and a historically key level on Dogecoin's weekly RSI.
Kevin notes that since DOGE broke out of its 1.5-year bear market in 2022, each revisit to this RSI support zone has marked a macro higher low, followed by higher highs. 
If this zone fails, it will break that structure and could mark the beginning of a longer-term bearish phase. 
If it holds, Kevin sees a strong risk-reward setup with upside continuation likely, especially if Bitcoin dominance remains high.
Trader Tardigrade drew comparisons to DOGE's previous cycle moves—$0.0003 to $0.0026 to $0.009—and suggests the current cycle could mirror that trajectory, potentially leading to jumps from $0.42 to $1.46 to $4.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> jumped from $0.0003 to $0.0026 to $0.009 in the last cycle &#x1f525; In this cycle, <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> could see similar jumps, from $0.42 to $1.46 to $4 &#x1f680;<a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a>/M1 <a href="https://t.co/k6kbCrqdVW">pic.twitter.com/k6kbCrqdVW</a>
&mdash; Trader Tardigrade (@TATrader_Alan) <a href="https://twitter.com/TATrader_Alan/status/1938236825728127080?ref_src=twsrc%5Etfw">June 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Statistics: Bitinfocharts shows a rise in wallet accumulation: wallets holding 10 million–100 million DOGE increased from 747 (as of May 25) to 783 (June 25) while wallets with 1 million–10 million DOGE rose from 4,204 to 4,228.
Coinglass data shows DOGE derivatives open interest increased 2.7% to $.8 billion, while volume expanded 11.2% to $3 billion. Liquidations in the past 24 hours stood at $4.09 million with long liquidations at $2.99 million.
Community News: Bitwise Asset Management has filed updated <a href="https://www.sec.gov/Archives/edgar/data/2053791/000121390025058120/ea0246815-s1a1_bitwise.htm">S-1</a> forms with the SEC, including a Bitwise Dogecoin ETF, a move that would provide exposure to DOGE without requiring direct token ownership.
Dogecoin core contributor Mishaboar <a href="https://x.com/mishaboar/status/1936838567445102769">voiced</a> criticism toward major influencers in the DOGE space. 
He claims many who previously amplified Elon Musk's pro-Trump messages have begun deleting posts and walking back their public stance. 
Mishaboar slammed this behaviour as cowardly, warning that such influence, even when retracted, has real impact.
"These influencers built their platforms on Dogecoin's back, and now they're using it to amplify misguided political and billionaire-driven narratives," he said.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46102135/bitcoin-ethereum-xrp-holders-sitting-on-profits-while-dogecoin-trails-report">Bitcoin, Ethereum, XRP Holders Sitting On Profits, While Dogecoin Trails: Report</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

Dogecoin ETF Nears But DOGE Down 5% In 7 Days: Bear Market Incoming?

Susquehanna analyst James Friedman maintains MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) with a Positive and raises the price target from $2840 to $2975.

Susquehanna Maintains Positive on MercadoLibre, Raises Price Target to $2975

Edgewise Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWTX#NASDAQ">EWTX</a>), a biotechnology company focused on developing treatments for rare muscle disorders, recently unveiled promising results from its <a href="https://www.benzinga.com/general/health-care">sevasemten program</a> for Becker muscular dystrophy (BMD) and Duchenne muscular dystrophy (DMD). 
Both are progressive genetic disorders characterized by muscle weakness and degeneration, with DMD typically being more severe and having an earlier onset than BMD.
On Thursday, the company announced data from MESA. This open-label extension trial provides continued access to sevasemten to participants with Becker who were previously enrolled in ARCH or completed CANYON, GRAND CANYON, or DUNE.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/04/44610702/edgewise-therapeutics-sees-meaningful-hcm-treatment-gains-with-edg-7500-in-phase-2-study" rel="noreferrer noopener">Edgewise Therapeutics Sees Meaningful HCM Treatment Gains With EDG-7500 In Phase 2 Study</a>
As of the&nbsp;March 2025&nbsp;data cut, 99% of eligible participants (n=85) are enrolled in MESA. The MESA data demonstrated sustained disease stabilization.
CANYON participants who rolled over to MESA showed increased North Star Ambulatory Assessment (NSAA) scores over 18 months (0.8 point improvement from baseline), with a trend toward improvement in placebo participants switching to sevasemten (0.2 point improvement since <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/n46110778/edgewise-therapeutics-reports-positive-results-on-sevasemten-program-for-becker-and-duchenne-muscu" rel="noreferrer noopener">initiation of sevasemten)</a>.
NSAA measures functional motor abilities in ambulant (who can walk) children with Duchenne. During the 18 months of sevasemten treatment, participants&#8217; NSAA scores continued to diverge relative to the expected functional declines seen in multiple Becker natural history studies.
Further, NSAA scores for ARCH participants who rolled over to MESA remained stable after three years of treatment. Sevasemten demonstrates a favorable safety profile after up to three years of treatment.&nbsp;
Edgewise recently completed a Type C meeting with the U.S. Food and Drug Administration (FDA).
While the FDA deemed the CANYON data insufficient for accelerated approval, the Agency reiterated that NSAA is a clinically meaningful endpoint for traditional approval.
Accelerated approval is an FDA pathway that allows for earlier approval of drugs for serious conditions that fill an unmet medical need, based on a surrogate endpoint (a measure that is reasonably likely to predict clinical benefit). 
However, it requires confirmatory trials post-approval. Traditional approval, on the other hand, typically requires more extensive clinical trial data demonstrating direct clinical benefit.
GRAND CANYON is highly powered to show a statistically significant difference in NSAA versus placebo over 18 months and is on track for topline data in the fourth quarter of 2026.&nbsp;
The company also announced topline data from its Phase 2 Duchenne trials, LYNX and FOX.
The goals were to explore a range of doses to assess safety and identify a potentially beneficial dose for Phase 3. Across both studies, sevasemten was well-tolerated at target doses.
LYNX is an ongoing Phase 2 trial to evaluate the effect of sevasemten on safety, biomarkers of muscle damage, and function in four- to nine-year-old participants with Duchenne treated with sevasemten.
The company identified a dose of 10 mg to evaluate in Phase 3.&nbsp;
Similar to the LYNX design, FOX is an ongoing Phase 2 trial to evaluate the effect of sevasemten on safety, biomarkers of muscle damage, and function in six- to 14-year-old participants with Duchenne who have been previously treated with gene therapy.
The company plans to meet with the FDA in the fourth quarter of 2025 to discuss a Phase 3 design, including input on the patient population and endpoints, with plans to initiate the pivotal study in 2026.
Price Action: EWTX stock is down 11.6% at $12.68 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/06/46117699/poet-technologies-stock-surges-on-ai-award-manufacturing-momentum" target="_blank" rel="noreferrer noopener">POET Technologies Stock Surges On AI Award, Manufacturing Momentum</a></li>
</ul>
Photo via Shutterstock

Biotech

Health Care

EWTX

No Accelerated FDA Approval For Edgewise's Rare Muscular Disease Drug; Shares Fall

<a href="https://www.bloomberg.com/news/articles/2025-06-26/no-decision-imminent-on-next-fed-chair-white-house-says">https://www.bloomberg.com/news/articles/2025-06-26/no-decision-imminent-on-next-fed-chair-white-house-says</a>

'Trump Decision on Next Fed Chair Not Imminent, White House Says'- Bloomberg

Stifel analyst David Grossman maintains Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) with a Hold and lowers the price target from $156 to $152.

PAYX

Stifel Maintains Hold on Paychex, Lowers Price Target to $152

<a href="https://www.bloomberg.com/news/articles/2025-06-26/meta-in-talks-to-buy-ai-voice-startup-playai-in-push-for-talent" title="https://www.bloomberg.com/news/articles/2025-06-26/meta-in-talks-to-buy-ai-voice-startup-playai-in-push-for-talent">https://www.bloomberg.com/news/articles/2025-06-26/meta-in-talks-to-buy-ai-voice-startup-playai-in-push-for-talent</a>

'Meta in Talks to Buy AI Voice Startup PlayAI in Push for Talent' - Bloomberg News

<ul>
<li>Stephen H. Rusckowski elected as Chairman of the Supervisory Board after AGM; former Chairman Lawrence A. Rosen did not stand for re-election following 12 years of service</li>
<li>Shareholders approve all resolutions at AGM – including first-ever annual cash dividend and a synthetic share repurchase authorization of up to $500 million</li>
</ul>
QIAGEN N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QGEN#NYSE">QGEN</a>, Frankfurt Prime Standard: QIA))) today announced that its Supervisory Board has elected Stephen H. Rusckowski as Chairman following the Annual General Meeting of Shareholders (AGM) on June 26, 2025.
He succeeds Lawrence A. Rosen, who did not stand for re-election after serving for 12 years on the Supervisory Board. The Dutch Corporate Governance Code indicates that Directors of public companies should not serve more than 12 years for a company on their Supervisory Board.
At the AGM, where 80.4% of QIAGEN's issued shares were represented, shareholders approved all proposed resolutions, including the initiation of an annual cash dividend and a new share repurchase authorization of up to $500 million.
Additionally, Prof. Dr. Elaine Mardis stepped down from the Supervisory Board after deciding not to stand for re-election. Prof. Dr. Mardis brought important scientific expertise to the Board since 2014, especially through her service on the Science &amp; Technology and Human Resources &amp; Compensation Committees.
Following the AGM, QIAGEN's Supervisory Board now consists of eight members, reflecting the implementation of a plan announced in 2024 to return to a size consistent with historical levels and continuing to represent all the necessary expertise to support the future development of QIAGEN in a highly effective manner.
The AGM approved the re-appointment for one-year terms of the following Board members: Dr. Metin Colpan, Dr. Toralf Haag, Prof. Dr. Ross L. Levine, Mr. Bert van Meurs, Ms. Eva van Pelt, Dr. Eva Pisa, Ms. Elizabeth Tallett and Mr. Stephen H. Rusckowski.
Shareholders also approved the initiation of QIAGEN's first-ever annual cash dividend - a milestone that reflects QIAGEN's strong financial position and disciplined capital allocation strategy, which includes dividends in addition to organic investments, value-creating acquisitions and share repurchases.
The first dividend payment will be $0.25 per ordinary share, totaling approximately $54 million, with a record and ex-date of July 2, 2025, and payment date of July 10, 2025.
In addition, the AGM approved a new synthetic share repurchase authorization of up to $500 million, reinforcing QIAGEN's commitment to returning capital to shareholders while preserving financial flexibility to invest in innovation and long-term growth.

Dividends

Buybacks

Management

QGEN

QIAGEN Elects Stephen Rusckowski As Chairman Of Supervisory Board; Shareholders Approve Annual Cash Dividend Of $0.25/Shr And Synthetic Share Repurchase Authorization Of Up To $500M

A new film about Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) is in the works. Here's why Meta CEO<a href="https://www.benzinga.com/topic/mark-zuckerberg"> Mark Zuckerberg</a> might not be happy about seeing his company on the big screen.
What Happened: A sequel to the 2010 film "The Social Network," which Zuckerberg <a href="https://www.benzinga.com/news/21/10/23381351/5-things-you-might-not-know-about-facebooks-mark-zuckerberg-2">was highly critical of</a>, is in the works.
Tentatively titled "The Social Network Part II," the film comes from the Sony Group Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) unit of Sony Pictures, according to a report from <a href="https://deadline.com/2025/06/the-social-network-sequel-aaron-sorkin-1236439539/">Deadline</a>. According to the report, the film will not be a straight sequel, but rather a follow-up to the first film.
Aaron Sorkin, who wrote the screenplay for the first film, is returning to write the screenplay and direct the film. David Fincher, who directed the first film, is not mentioned in the report on the sequel.
While the first film was based on the book "The Accidental Millionaires" by Ben Mezrich, the new movie will focus on the story "The Facebook Files" from the Wall Street Journal. That story exposed the inner workings of Facebook and the potential harm it has done.
Sorkin has been vocal about wanting to do a follow-up to the hit 2010 movie; now it appears he&#8217;s found his angle with "The Facebook Files."
The writer and director also said in an interview last year that he believes Facebook played a role in the Jan. 6 attack on the U.S. Capitol. The new film won't focus solely on Jan. 6 or the 2020 election. It will also examine the potential harmful impact of Facebook on teenagers and preteens.
Todd Black, Peter Rice, Stuart Besser and Sorkin will produce the film. A production date has not been announced, with Sorkin likely working on casting first.
It is unknown if Jesse Eisenberg, who played Zuckerberg in the 2010 film, will return for the follow-up movie.
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul class="wp-block-list">
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
Why It's Important: The 2010 film focused on the early days of Facebook&#8217;s creation. It examined several disputes, including those between Zuckerberg and key figures in the company&#8217;s early days, such as the Winklevoss twins and Eduardo Saverin.
Zuckerberg has criticized that film on several occasions, saying it had many inaccuracies.
"It's interesting what stuff they focused on getting right; like, every single shirt and fleece that I had in that movie is actually a shirt or fleece that I own. So there's all this stuff that they got wrong and a bunch of random details that they got right," Zuckerberg said.
Zuckerberg may be even more concerned about the second movie as it will center on a report that sheds a negative light on the social media company.
"The Social Network" grossed $97 million domestically and $225 million globally, according to BoxOfficeMojo.
The film won three Academy Awards for Best Adapted Screenplay, Best Film Editing and Best Original Score. The film was nominated for eight Academy Awards, including top categories like Best Picture, Best Director and Best Actor for Eisenberg.
Meta Platforms&#8217; stock is up 233% over the last five years. Shareholders will closely watch the timing of the movie release to see if the film could harm the company's brand and share price.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/entertainment/25/04/44854679/time-100-most-influential-people-includes-elon-musk-mark-zuckerberg-alex-karp-and-more-public-company-ceos">Time 100 Most Influential People Includes Elon Musk, Mark Zuckerberg, Alex Karp And More Public Company CEOs</a></li>
</ul>
Photo: Shutterstock

Entertainment

Sony Group Corporation American Depositary Shares

SONY

Mark Zuckerberg Hated 'The Social Network' Film: Don't Tell Him A Sequel Is Coming

Stifel analyst Brian Chin maintains Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) with a Buy and raises the price target from $130 to $145.

Stifel Maintains Buy on Micron Technology, Raises Price Target to $145

<a href="https://www.youtube.com/watch?v=vIRh3tzaJ48" title="https://www.youtube.com/watch?v=vIRh3tzaJ48">https://www.youtube.com/watch?v=vIRh3tzaJ48</a>

Macro Economic Events

Politics

Global

Economics

White House Says No Indication That Any Enriched Uranium Was Removed From Any Sites In Iran

Stifel analyst Matthew Smith maintains General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) with a Buy and lowers the price target from $65 to $56.

Stifel Maintains Buy on General Mills, Lowers Price Target to $56

Stifel analyst Erik Rasmussen maintains Equinix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) with a Buy and lowers the price target from $1050 to $1010.

EQIX

Stifel Maintains Buy on Equinix, Lowers Price Target to $1010

Press Releases

Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting

Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference

Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting

Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025

Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference

Silence Therapeutics Welcomes Tim McInerney to Board of Directors

Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera

Comments

Silence Therapeutics

空売り

Silence Therapeutics (NASDAQ:SLN) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル